As shown in Figures ?Figures66 and ?and7,7, the examined cell lines are characterized by a different expression pattern of the rAAV transmission genes in both constitutive (37C) and hyperthermia (43C) conditions. lot of attention in the field of cancer treatment due to many advantages. In this study, the effect of elevated heat around the transduction efficiency of rAAV vectors on CRC cells with different origin and gene profile was examined. The effect of heat shock around the penetration of rAAV vectors into CRC cells in relation with the expression of HSP and AAV receptor genes was tested. It was found that the examined cells under hyperthermia (43C, 1?h) are transduced at a higher level than in normal conditions (37C). The results also indicate that analyzed RKO, HT-29, and LS411N cell lines express HSP Rabbit polyclonal to TRIM3 genes at different levels under both 37C and 43C. Moreover, the results showed that this expression of AAV receptors increases in response to elevated heat. The study suggests that increased rAAV transfer to CRC can be achieved under elevated heat conditions. The obtained results provide information relevant to the design of new solutions in CRC therapy based on the combination of hyperthermia, chemotherapy, and gene therapy. 1. Introduction Colorectal malignancy (CRC) is one of the most common cancers in human population [1]. According to data from 2018, CRC is the second cause of oncology patient deaths in the world. The incidence and mortality rate of CRC in 2018 was above 1.8?million and nearly 0.9?million patients, respectively. Epidemiological studies indicate a continuous increase in cases of CRC [1]. At the same time, there is a dynamic progress in the field of explaining molecular mechanisms of CRC growth, defining predictors, as well as developing and implementing new drugs and therapeutic programs for patients [2C5]. The clinical centers especially administer drug programs based on fluoropyrimidine, leucovorin and oxaliplatin (5-fluorouracil-leucovorin-oxaliplatin, FOLFOX program) [6]. A great achievement was the introduction of targeted biological drugs to inactivate the key receptor/signaling proteins in CRC. The representative example is the presence in the clinics of cetuximab (anti-EGFR monoclonal antibody) and bevacizumab (anti-VEGF monoclonal antibody). These drugs, however, have functional limitations and very often numerous side effects. For example, cetuximab is most of all used in patients with a nonmutated (wild type) KRAS gene [7, 8]. Moreover, in the CRC treatment area, solutions of chemotherapy combined with hyperthermia are launched. It is indicated that this elevated temperature increases the therapeutic activity of the used cytotoxic drugs, especially in cases of peritoneal carcinomatosis [9, 10]. Increasing the permeability of tumor cell membranes, blood vessels and changes in the response of the immune system are emphasised among the postulated antineoplastic mechanisms of hyperthermia [11]. The importance of heat shock 4-Hydroxyisoleucine proteins (HSP) is usually highlighted in the response of tumor cells to hyperthermia and cytostatics are emphasized [12, 13]. Hyperthermia protocols include local application of elevated heat or heating the whole body. Currently, nanotechnology proposes different ways of generating the phenomenon of hyperthermia, including laser, microwaves, radiofrequency, and ultrasound sources [14]. Great importance is usually attached to the development of the HIPEC strategy (hyperthermic intraperitoneal chemotherapy) [15]. Cytoreductive surgery and HIPEC extends the survival of patients with CRC [16, 17]. The results of a meta-analysis published recently by Desidero et al. including papers published in the last 30 years, showed that HIPEC significantly increases the survival time of patients with gastric cancers [18]. The number of new HIPEC clinical protocols in the field of CRC is growing [19, 20]. The possibilities of using the oncology hyperthermia strategy in increasing the effectiveness of malignancy gene therapy based on recombinant adeno-associated vectors (rAAV) are also indicated [21C23]. Hyperthermia may induce both an increase in the expression of transgenes under the 4-Hydroxyisoleucine control 4-Hydroxyisoleucine of temperature-dependent inducible promoters [24, 25], and increase the vector transduction efficiency in a mechanism dependent on the HSP manifestation [22, 26]. Advancements in knowledge of CRC biology enable the introduction of ultra-modern therapies and medicines, such as gene transfer/modification strategies. Gene therapy can be a guaranteeing proposition in tumor 4-Hydroxyisoleucine treatment. Relating to researchers, gene therapy predicated on the CRISPR-Cas9 technique.